Tuesday Oct 13 | Applied Clinical Trials - Sites
Late Phase Patient Reported Outcomes
The growing need to establish a drug's safety and long-term efficacy in a given population has increased the number of late-phase studies performed by the pharmaceutical industry over the past decade.
Pfizer Used Docs Accused of Misconduct to Prep Geodon Submission to FDA
Pfizer used three physicians who have since been accused of misconduct to prepare submissions to the FDA for the approval of the antipsychotic Geodon , according to a whistleblower lawsuit brought by a Harrisburg, Pa., doctor.
Exclusive savings on ADHD products and much, much more! Start saving today! switching to geodon 09/19/09 Cindy Topics: changing medication My son is currently taking invega, he has been on this for a while.
Pfizer paid agency thousands to boost drug sales, suit claims
Pfizer Inc. paid the National Alliance for the Mentally Ill hundreds of thousands of dollars and its former president thousands more, turning the organization into a "Trojan horse" for an illegal marketing scheme that helped boost the schizophrenia drug Geodon's sales by millions of dollars a year, according to a lawsuit unsealed this week.
Oregon Reached Settlement With Pfizer
The pharmaceutical company Pfizer has reached a $33-million settlement with Oregon and 42 other states after being accused of illegally marketing a drug called Geodon.
Why the upsurge in False Claims Act cases against pharmaceutical companies for off-label promotion?
Lax Food and Drug Administration enforcement of its own regulations. That's the take of Brian Kenney of Kenney Egan in Philadelphia.
Colorado Gets $3.5 Million From Drug Settlement.Loading...
Business Journal September 2, 2009 SECTION: ISSN: 0890-2127 ACC-NO: 207084391 LENGTH: 558 words HEADLINE: Colorado gets $3.5 million from drug settlement.
Arizona collects piece of Pfizer settlement
Pfizer Inc. reached a separate $33 million settlement with 24 states, including Arizona, over potentially improper marketing of a drug used to treat psychiatric disorders.
South Dakota Office of the Attorney G...
Attorney General Long Joins $33 Million Settlement with Pfizer Inc.
Attorney General Larry Long announced today that he, along with 42 other Attorneys General, reached a $33 million dollar settlement with Pfizer Inc.
State announces two major Medicaid fraud settlements with Pfizer
Washington Attorney General Rob McKenna says the state's share of a nationwide settlement with Pfizer Inc.
Pfizer must pay $58 million to Florida
Florida will receive a total of $58.2 million as part of a global settlement with Pfizer Inc.A The agreement resolves civil and criminal allegations that Pfizer and its subsidiaries paid kickbacks and engaged in off-labeling marketing campaigns that improperly promoted numerous drugs that Pfizer manufactures, according to Attorney General Bill ...
Pfizer fined $2.3 billion over drug promotions
Pfizer will pay $2.3 billion to settle a U.S. investigation into illegal marketing of Bextra, Lyrica, Zyvox and Geodon.
FDA: Pfizer Ignored Warnings, Gets Record Fine
In 2005, the U.S. Food and Drug Administration warned Pfizer Inc. that its ads touting the antibiotic Zyvox as superior to similar drugs could endanger public health.
Attorney General Gansler Leads Settlement of Consumer Protection Claims Against Pfizer
Attorney General Douglas F. Gansler announced today that he, together with Delaware Attorney General Biden's Office, led a group of 43 Attorneys General in reaching a $33 million dollar consumer protection settlement with Pfizer Inc.
Pfizer Pays A Record Amount To Settle Federal And State Fraud...
Pfizer, Inc. announced today it has agreed to plead guilty to criminal conduct and to pay more than $2 billion in criminal and civil fines, penalties and damages to settle allegations made in multiple whistleblower lawsuits that the pharmaceutical giant defrauded Medicare, Medicaid and other government-funded health care programs in connection with ...
Colorado to get $3.5M in latest Pfizer settlements
Colorado will get $3.5 million as its share of a pair of multistate legal settlements with drugmaker Pfizer Inc.
Medical News & Perspectives: Fda Panel OKs 3 Antipsychotic Drugs for...
JAMA. 2009;302 :833-834. Despite safety concerns, a US Food and Drug Administration advisory panel recommended in June that the agency approve 3 atypical antipsychotic drugs for the treatment of children and adolescents with bipolar disorder or schizophrenia.
Schering-Plough gets FDA approval for schizophrenia/bi-polar disorder drug
Schering-Plough Corp.'s new drug for schizophrenia and bipolar disorder, Saphris, has been approved by the Food and Drug Administration, the company said Friday.
Antipsychotics and the pediatric community
LAURENCE GREENHILL, MD Incoming head of AACAP An advisory committee to the Food and Drug Administration voted to approve two drugs for teens and pre-adolescents with schizophrenia and bipolar mania, and gave a split vote on a third drug.
Antipsychotics and the pediatric community
LAURENCE GREENHILL, MD Incoming head of AACAP An advisory committee to the Food and Drug Administration voted to approve two drugs for teens and pre-adolescents with schizophrenia and bipolar mania, and gave a split vote on a third drug.
Also on Topix